- Tytuł:
- Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
- Autorzy:
- Źródło:
- The Lancet; November 2023, Vol. 402 Issue: 10413 p1648-1659, 12p
Periodyk